XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenue      
Total revenue $ 773,915 $ 687,180 $ 560,618
Operating expenses      
Cost of services, excluding depreciation and amortization 596,142 539,211 467,805
General and administrative expenses 62,077 49,116 41,482
Depreciation and amortization 17,517 18,350 18,280
Provision for doubtful accounts 0 0 (1,363)
Impairment of goodwill and intangible assets 0 0 1,994
Total expenses 675,736 606,677 528,198
Income from operations 98,179 80,503 32,420
Other (expense) income      
(Loss) income from equity method investments (4,306) 3,694 (6,901)
Gain on sale of equity method investment 2,193 99,839 0
Interest expense (5,394) (9,499) (4,733)
Interest income 1,571 2,813 2,024
Unrealized loss on investments (10,745) 0 0
Other (loss) income (3,750) 1,077 3,030
Total other (expense) income, net (20,431) 97,924 (6,580)
Income before provision for income taxes 77,748 178,427 25,840
Provision for income taxes 28,454 56,107 8,167
Net income 49,294 122,320 17,673
Net (loss) income attributable to noncontrolling interests (24,564) 84,454 3,557
Net income attributable to Apollo Medical Holdings, Inc. $ 73,858 $ 37,866 $ 14,116
Earnings per share – basic (in dollars per share) $ 1.69 $ 1.04 $ 0.41
Earnings per share – diluted (in dollars per share) $ 1.63 $ 1.01 $ 0.39
Capitation, net      
Revenue      
Total revenue $ 593,224 $ 557,326 $ 454,168
Risk pool settlements and incentives      
Revenue      
Total revenue 111,627 77,367 51,098
Management fee income      
Revenue      
Total revenue 35,959 34,850 34,668
Fee-for-service, net      
Revenue      
Total revenue 26,564 12,683 15,475
Other income      
Revenue      
Total revenue $ 6,541 $ 4,954 $ 5,209